| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |